AIM has worked closely with the pharmaceutical industry
since 1995. Initially we launched PIRC, our clinical trials
division and in 2001 the MedEmerg Infusion services division
was launched. Today, AIM is one of Canada’ fastest
growing clinical research management organizations providing
pharmaceutical research services in community and hospital
based sites. Currently there are more than 30 active sites
that provide research services and we are involved in over
40 clinical trials at various stages. At the same time AIM
is Canada’s leading provider of intravenous infusions,
providing more than 26,000 infusions annually through its
network of 37 clinical sites. Together with its joint-venture
partner, AIM is developing a national network of sites and
expanding its range of services for the pharmaceutical industry.
